MyFinsight
Home
Blog
About
Net decrease in
cash, cash...
-$49,970K
(68.39%↑ Y/Y)
Share-based compensation
expense
$6,404K
(-66.37%↓ Y/Y)
Depreciation and
amortization
$1,067K
(-67.96%↓ Y/Y)
Operating lease
right-of-use assets
-$588K
(73.69%↑ Y/Y)
Prepaid expenses and
other assets
-$469K
(-105.47%↓ Y/Y)
Deferred income tax
provision (benefit)
$326K
(119.79%↑ Y/Y)
Proceeds from the
exercise of share options...
$1K
(-66.67%↓ Y/Y)
Net cash used in
operating activities
-$49,606K
(68.83%↑ Y/Y)
Net cash used in
investing activities
-$265K
(75.95%↑ Y/Y)
Net cash used in
financing activities
-$50K
(41.86%↑ Y/Y)
Effect of exchange rate
changes on cash, cash...
-$49K
(-102.15%↓ Y/Y)
Canceled cashflow
$8,854K
Canceled cashflow
$1K
Net loss
-$50,333K
(63.97%↑ Y/Y)
Purchases of property and
equipment
$265K
(-75.95%↓ Y/Y)
Payments of finance lease
obligations
$51K
(-42.70%↓ Y/Y)
Research and development
incentives receivable
$6,516K
(-68.64%↓ Y/Y)
Operating lease
liabilities
-$711K
(73.23%↑ Y/Y)
Accrued expenses and
other current...
-$597K
(-161.42%↓ Y/Y)
Deferred revenue
-$244K
(98.04%↑ Y/Y)
Accounts payable
-$59K
(-105.46%↓ Y/Y)
Back
Back
Cash Flow
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)
source: myfinsight.com